European Research Infrastructure on Highly Pathogenic Agents

Access to leading European high containment (BSL4 laboratories) & complementary facilities
Read more

Our Services for COVID-19 research

Learn more on access opportunities to our BSL3 and complementary facilities
Read more

ERINHA free of charge Special SARS-CoV-2 transnational access (TNA)

Learn more on application modalities
Read more

ERINHA Scientific Strategy

From Discovery to Prevention
Read more

Follow our twitter: @ERINHA_RI

You can contact us here

Access to our intranet here

Download our portfolio here

Science
Services

Erinha offers in-person and remote access to high containment facilities and expertise allowing scientists to advance research on highly pathogenic agents

Read more

Training

ERINHA provides biosecurity and biosafety trainings, including working safely in high containment conditions, operating and maintaining high containment (BSL3 & BSL4) facilities

Read more

Covid-19

ERINHA supports efforts to advance research on SARS-CoV2/COVID-19 by offering access to a large range of high containment in-vitro and in-vivo capacities

Read more

TNA
call

ERINHA provides free of charge access to high containment and complementary facilities through TransNational Access Calls.

Read more

Value to
Europe

European Bio-containment capacity enabling Europe to address the challenges posed by high-consequence pathogens

Read more

Collaborative
projects

ERINHA both participates and coordinates European and international projects

Read more

ERINHA's concept

European distributed research infrastructure of Bio Safety Level 3 and 4 (BSL3 & BSL4) facilities providing access to perform large-scale research projects
Read more

Scientific strategy

From Discovery to Prevention: ERINHA’s Research Approach
Read more

Pathogens We Study

ERINHA focuses on high-consequence pathogens of Risk Group 4 with no available countermeasures and high transmission and mortality rates
Read more

Unique facilities and scientists

The cutting edge research performed at ERINHA is made possible by a range of highly specialised European bio-contained facilities and unique expertise
Read more

News & Events

Newsletter January 2021
1-2 February 2021 ― RI-VIS Africa-Europe Symposium on research infrastructures, virtual meeting
11/01/2021 Making experimental data tables in the life sciences more FAIR: a pragmatic approach
All news

“The current, unprecedented in modern times, global pandemic of COVID-19, shows the necessity of global collaborative approach. ERINHA was created to allow academia and industry to have easier access to Europe’s top high containment research facilities to advance research on highly infectious diseases and develop more effective diagnostics, therapeutics, and vaccines. This cooperative scheme allows rapid testing of new or repurposed drugs, optimized in vivo efficacy studies, and opens the door to industry, SMEs and public researchers, to test their innovative products against existing and emerging infectious diseases.”

Dr Hervé RAOUL, ERINHA Director General

Members

Our adress

ERINHA AISBL
Rue Montoyer 10 B –
1000 Brussels

ERINHA AISBL CCU
101, rue Tolbiac – 75013 PARIS

contact@erinha.eu

Extra links

Newsletters

Subscribe for latest articles and resources

©ERINHA 2020 by MLCOM / Legal mentions & Personal data protection policy